Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04551495 |
Title | Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) (ROSALINE) |
Acronym | ROSALINE |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Jules Bordet Institute |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FRA | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UZ Brussel | Brussels | 1090 | Belgium | Details | ||
UCL Saint-Luc | Brussels | 1200 | Belgium | Details | ||
Institut Jules Bordet | Bruxelles | 1070 | Belgium | Details | ||
Grand Hôpital de Charleroi | Charleroi | 6000 | Belgium | Details | ||
UZ Gent | Gent | 9000 | Belgium | Details | ||
UZ Leuven | Leuven | 3000 | Belgium | Details | ||
CHU Namur - Sainte Elisabeth | Namur | 5000 | Belgium | Details | ||
Institut Bergonié | Bordeaux | 33076 | France | Details | ||
Institut Curie | Paris | 75248 | France | Details | ||
Institut Gustave Roussy | Villejuif | 94805 | France | Details |